Form 8-K - Current report:
SEC Accession No. 0000950123-09-023559
Filing Date
2009-07-20
Accepted
2009-07-20 17:24:04
Documents
4
Period of Report
2009-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c88086e8vk.htm 8-K 10940
2 EXHIBIT 10.1 c88086exv10w1.htm EX-10.1 54175
3 EXHIBIT 99.1 c88086exv99w1.htm EX-99.1 7699
4 GRAPHIC c88086p8808601.jpg GRAPHIC 9890
  Complete submission text file 0000950123-09-023559.txt   88212
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 09953694
SIC: 2835 In Vitro & In Vivo Diagnostic Substances